Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125950971 | 12595097 | 1 | I | 20160719 | 20160726 | 20160726 | PER | US-TAKEDA-2016MPI006577 | TAKEDA | 89.00 | YR | M | Y | 0.00000 | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125950971 | 12595097 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | 2.5 MG, 1/WEEK | U | 21602 | 2.5 | MG | INJECTION | /wk | |||||
| 125950971 | 12595097 | 2 | C | HYDROCODONE | HYDROCODONE | 1 | Unknown | 10 MG, UNK | U | 0 | 10 | MG | |||||||
| 125950971 | 12595097 | 3 | C | ELIQUIS | APIXABAN | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125950971 | 12595097 | 1 | Mantle cell lymphoma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125950971 | 12595097 | Arthralgia | |
| 125950971 | 12595097 | Back pain | |
| 125950971 | 12595097 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125950971 | 12595097 | 1 | 20160715 | 0 |